You may be eligible if you are:
*Please note: If you have used plaque psoriasis medications other than risankizumab, such as TNF inhibitors, IL-17 inhibitors, IL-12/23 inhibitors, or other IL-23 inhibitors, you may be eligible to participate. These medications include Stelara (ustekinumab), Cosentyx (secukinumab), Siliq (brodalumab), Taltz (ixekizumab), Tremfya (guselkumab), Ilumya (tildrakizumab), Enbrel (etanercept) or biosimilar (Erelzi, Eticovo), Remicade (infliximab) or biosimilar (Avsola, Inflectra, Ixifi, Renflexis), Humira (adalimumab) or biosimilar (Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz), or Cimzia (certolizumab). If you have used any of these medications during or just prior to pregnancy, the registry staff can help determine your eligibility.
Third-party trademarks used herein are trademarks of their respective owners.
Complete this form and a registry team member will contact you with more information about participating in the Registry.
* marks required field.
I authorize the GLOW Pregnancy Registry to contact me and/or leave a message for me at these numbers or to contact me via email at the address listed below. I agree to the Registry referencing the GLOW Pregnancy Registry in messages or emails.